Europe lymphedema treatment market is expected to gain significant growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the Europe lymphedema treatment Market is growing with a CAGR of 7.8% in the forecast period of 2022 to 2029 and is expected to reach USD 458.39 million by 2029 from 256.09 million in 2022. Rising healthcare expenditure and escalation in innovation and technologies are drivers which are expected to the growth of the market in the forecast period.

Lymphedema refers to swelling that generally occurs in upper and lower extremities. Sometimes both arms and both legs swell. Lymphedema is most commonly caused by the removal of or damage to lymph nodes as a part of cancer treatment. It results from a blockage in lymphatic system, which is part of immune system. Stems from a damaged lymphatic system, can lead to infections, disfigurement, debilitating pain and disability. There is no cure for lymphedema.

Lymphedema treatment involves multiple therapies instead of standard treatment, since the patients are dissatisfied or don’t get cured with the conventional treatment of lymphedema. They approach the alternative treatment which offers more control over health care decisions, and the alternatives are found to be more compatible with the patient’s health system..–62b564055af8a181d90389cf–62b56426cf13522910e45b7f

Leave a Reply

Your email address will not be published.